3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase EARLY_PHASE1
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Sarcoma
1
Myeloid
1
Conditions
Colorectal Neoplasms
18
Carcinoma, Non-Small-Cell Lung
14
Breast Neoplasms
14
Lung Neoplasms
12
Head and Neck Neoplasms
10
Rectal Neoplasms
8
Prostatic Neoplasms
7
Mouth Neoplasms
5
Glioblastoma
5
Esophageal Neoplasms
5
Colonic Neoplasms
5
Central Nervous System Neoplasms
5
Pancreatic Neoplasms
4
Oropharyngeal Neoplasms
4
Neoplasm Metastasis
4
Hypopharyngeal Neoplasms
4
Gliosarcoma
4
Carcinoma
4
Squamous Cell Carcinoma of Head and Neck
3
Sarcoma
3
Ovarian Neoplasms
3
Neuroblastoma
3
Neoplasms
3
Laryngeal Neoplasms
3
Brain Neoplasms
3
Uterine Cervical Dysplasia
2
Turcot syndrome
2
Tongue Neoplasms
2
Salivary Gland Neoplasms
2
Recurrence
2
Interventions
Cyclophosphamide
18
Etoposide
12
Cisplatin
11
Temozolomide
10
Vincristine
9
Radiotherapy
9
Magnetic Resonance Spectroscopy
9
Filgrastim
8
Irinotecan
7
Carboplatin
7
X-Rays
6
Phantoms, Imaging
6
Topotecan
5
Specimen Handling
5
Peripheral Blood Stem Cell Transplantation
5
Nuclear Medicine Department, Hospital
5
Thiotepa
4
Radiation
4
Lomustine
4
Biopsy
4
Bevacizumab
4
tipifarnib
3
sargramostim
3
palbociclib
3
Methotrexate
3
HhAntag691
3
Chemotherapy, Adjuvant
3
ulixertinib
2
tazemetostat
2
sonidegib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Medulloblastoma
×
Celecoxib
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled
NCT01356290
2026-02-23
MEMMAT
Medical University of Vienna
Phase 2
Recruiting
232 enrolled